1
Clinical Trials associated with Donor NK cell(First Affiliated Hospital of Xi'an Jiaotong University)Trial of Donor Immune Cell Therapy for Acute Myeloid Leukemia.
This study aims to introduce a new technology of donor NK cell infusion. NK cells defend against viruses and cancer cells in vivo whereas this effect declines in patiens with tumors. In this study, NK cells will be separated from donated peripheral blood or umbilical cord blood. Eligible NK cells will be infused to patients with Acute myeloid leukemia (AML). This new therapy will probably induce their sustained remission and reduce recurrences.
100 Clinical Results associated with Donor NK cell(First Affiliated Hospital of Xi'an Jiaotong University)
100 Translational Medicine associated with Donor NK cell(First Affiliated Hospital of Xi'an Jiaotong University)
100 Patents (Medical) associated with Donor NK cell(First Affiliated Hospital of Xi'an Jiaotong University)
100 Deals associated with Donor NK cell(First Affiliated Hospital of Xi'an Jiaotong University)